Brain cell transplant tested for Parkinson's
NCT ID NCT07102342
Summary
This is an early safety study for a new cell therapy called NouvNeu001 for people with advanced Parkinson's disease. Doctors will surgically transplant the cells into a specific part of the brain. Participants will need to take anti-rejection medication for about 6 to 9 months to support the transplanted cells.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PARKINSON DISEASE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Cornell University Weill Medical College
RECRUITINGNew York, New York, 10065, United States
Conditions
Explore the condition pages connected to this study.